Figure 1.
Cumulative incidence of NRM at 6 months by MCS at D28. (A) Training set: MCS 0 (dark blue): 3.7% (95% CI, 2.1%-6.0%), MCS 1 (light blue): 8.8% (95% CI, 5.7%-12.7%), MCS 2 (orange): 30.9% (95% CI, 24.2%-37.8%), MCS 3 (red): 70.8% (95% CI, 55.4%-81.8%). (B) Validation set: MCS 0: 3.6% (95% CI, 1.2%-8.3%), MCS 1: 11.3% (95% CI, 5.7%-18.9%), MCS 2: 40.1% (95% CI, 27.0%-52.9%), MCS 3: 49.0% (95% CI, 22.6%-71.1%).

Cumulative incidence of NRM at 6 months by MCS at D28. (A) Training set: MCS 0 (dark blue): 3.7% (95% CI, 2.1%-6.0%), MCS 1 (light blue): 8.8% (95% CI, 5.7%-12.7%), MCS 2 (orange): 30.9% (95% CI, 24.2%-37.8%), MCS 3 (red): 70.8% (95% CI, 55.4%-81.8%). (B) Validation set: MCS 0: 3.6% (95% CI, 1.2%-8.3%), MCS 1: 11.3% (95% CI, 5.7%-18.9%), MCS 2: 40.1% (95% CI, 27.0%-52.9%), MCS 3: 49.0% (95% CI, 22.6%-71.1%).

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal